Identification of Novel Plasma Protein Biomarkers for Early Clinical Stage Colorectal Carcinoma by High-Throughput Proteomics
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27219630 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Guoxing Yin und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300350, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Biomarkers, Tumor, Proteomics, Blood Proteins. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities Nankai University, General Program of Tianjin Bureau of Science and Technology.
Abstract (Originalsprache)
Early detection is critical for improving survival in colorectal carcinoma (CRC), underscoring the need for reliable early-stage biomarkers. Plasma protein biomarkers may support the detection of early-stage CRC. In this study, we profiled plasma from 24 patients with stages I–III CRC and 10 non-tumor participants, together with paired tumor and distant-normal tissues from the patients with CRC, to identify proteins preferentially elevated in stage I disease. Seven plasma proteins had higher abundance in stage I CRC than in stages II and III CRC and non-tumor participants; three of these proteins, HSPA8, ALDOA, and PDLIM1, were also elevated in stage I tumor tissues. In the discovery comparison of stage I CRC with non-tumor participants, HSPA8 alone achieved an internally cross-validated random forest classification accuracy of 88.9%, matching the three-protein model. Tissue upregulation was further supported by Western blotting. ELISA assessment included 32 participants with matched proteomic measurements and was subsequently expanded to 108 participants. The HSPA8-score was calculated by dividing the dilution-corrected HSPA8 concentration by the total protein amount in 10 μL of plasma. In the expanded cohort, random forest classification using this score achieved internally cross-validated accuracies of 74.47% for stage I versus stages II–IV CRC and 56.67% for stage I CRC versus non-tumor participants. The corresponding exploratory reference cutoffs were 0.066 and 0.029. These findings identify HSPA8 as a potential plasma protein biomarker for stage I CRC detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300350, China.
- Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin 300071, China.
- Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin Institute of Coloproctology, Tianjin 300121, China.
- Tianjin Union Medical Center, Nankai University, Tianjin 300071, China.
- Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China.
ORCID-Profile: Guofeng Feng
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities Nankai University
- General Program of Tianjin Bureau of Science and Technology
Zitieren
APA
Yin, G., Chen, Z., Feng, G., Lu, J., Jiao, C., Zhu, Z., Liu, L., & Xu, C. (2026). Identification of Novel Plasma Protein Biomarkers for Early Clinical Stage Colorectal Carcinoma by High-Throughput Proteomics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219630
Vancouver
Yin G, Chen Z, Feng G, Lu J, Jiao C, Zhu Z, et al. Identification of Novel Plasma Protein Biomarkers for Early Clinical Stage Colorectal Carcinoma by High-Throughput Proteomics. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219630
BibTeX
@article{Yin2026,
author = {Yin, Guoxing and Chen, Zhifei and Feng, Guofeng and Lu, Jiangtao and Jiao, Chenmeng and Zhu, Zhengmao and Liu, Lin and Xu, Chen},
title = {Identification of Novel Plasma Protein Biomarkers for Early Clinical Stage Colorectal Carcinoma by High-Throughput Proteomics},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27219630}
}
EUVIMED